Fusidic acid CAS:6990-06-3.
Fusidic acid is frequently prescribed for the treatment of skin conditions such as impetigo, infected eczema, and other localized bacterial infections. It is available in various topical forms, including creams, ointments, and gels, for easy application to affected areas. Patients are instructed to apply fusidic acid topically to clean, dry skin as directed by their healthcare provider. The frequency and duration of use depend on the severity of the infection and the individual's response to treatment. Healthcare professionals may recommend fusidic acid as monotherapy or in combination with other agents to manage bacterial skin infections more effectively. Monitoring for treatment response and potential adverse effects, such as skin irritation or allergic reactions, is essential during therapy. Adherence to the prescribed treatment regimen is crucial to achieve optimal outcomes and prevent the development of resistance. Patients should be advised to complete the full course of fusidic acid treatment even if symptoms improve to ensure the eradication of the infectious agent. Regular follow-up visits with healthcare providers help assess progress, adjust therapy as needed, and promote successful outcomes in the management of bacterial skin infections with fusidic acid. Collaboration between patients, caregivers, and healthcare professionals is key to ensuring safe and effective use of this antibiotic in dermatological practice.
Composition | C31H48O6 |
Assay | 99% |
Appearance | white powder |
CAS No. | 6990-06-3. |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |